13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03269071 (ClinicalTrials.gov) | May 17, 2017 | 30/8/2017 | Neural Stem Cell Transplantation in Multiple Sclerosis Patients | Neural Stem Cell Transplantation in Multiple Sclerosis Patient: a Phase I Study | Progressive Multiple Sclerosis | Drug: human fetal-derived Neural Stem Cells (hNSCs) | IRCCS San Raffaele | Fondazione Italiana Sclerosi Multipla | Completed | 18 Years | 55 Years | All | 4 | Phase 1 | Italy |